Results 61 to 70 of about 5,124 (246)
The Success of Sinister Right-Handers in Baseball [PDF]
, 2017 Description to be added.Cannot be left ...
Allen, Peter M. +2 more
core +2 more sources
New oral anticoagulants and their reversal agents [PDF]
, 2018 Atrial fibrillation is a commonly encountered pathology in medical practice, and its prevalence has shown a continuous rise over the past years. Atrial fibrillation has a significant impact on patients\u27 quality of life, not only due to the standard ...
Bodean, Oana +9 more
core +1 more source
Direct oral anticoagulants versus warfarin: is new always better than the old? [PDF]
, 2018 About 1.4 British million people are at risk of strokes due to non-valvular atrial fibrillation (AF) necessitating long-term anticoagulation. The vitamin K antagonist, warfarin, has a long half-life and narrow therapeutic range necessitating regular ...
Burn, John, Pirmohamed, Munir
core +1 more source
Neck‐vein thrombosis during spaceflight
British Journal of Clinical Pharmacology, Volume 92, Issue 1, Page 24-34, January 2026.Spaceflight imposes unique environmental challenges, including weightlessness, increased radiation exposure and confinement, which can lead to unexpected health effects. One such example is neck‐vein thrombosis, a condition rarely seen on Earth without predisposing factors such as venous catheters or infections.
Ulrich Limper, Jens Jordan
wiley +1 more source
Frontiers in Aging Neuroscience, 2021 Background: As there is a growing concern about the cerebral embolism events secondary to non-valvular atrial fibrillation (NVAF), novel oral anticoagulant (NOAC) has been more and more widely used as an anticoagulation treatment for the prevention of ...
Dan Xie +7 more
doaj +1 more source
Real-world experience with reversal of dabigatran by idarucizumab [PDF]
, 2021 Aims: Idarucizumab reverses the anticoagulant effect of dabigatran. We aimed to investigate real-world experience with idarucizumab and associated clinical outcomes.
Grove, Erik Lerkevang +4 more
core +1 more source
Intracerebral Hemorrhage: Advances, Knowledge Gaps, and Future Directions
MedComm, Volume 6, Issue 11, November 2025.This review provides a comprehensive synthesis of current research on the epidemiology, pathophysiological mechanisms, imaging characteristics, treatment delays, clinical management strategies, neural repair, and prognostic prediction of intracerebral hemorrhage (ICH).
Tao Liu +6 more
wiley +1 more source
Idarucizumab for a traumatic head injury patient taking dabigatran
International Journal of Emergency Medicine, 2018 Background Dabigatran is one of the four drugs currently used as a direct oral anticoagulant in Japan. Idarucizumab, which specifically targets dabigatran, was recently approved in Japan.
Shuhei Maruyama +7 more
doaj +1 more source
Consensus Guides on Stroke Thrombolysis for Anticoagulated Patients from Japan: Application to Other Populations [PDF]
Journal of Stroke, 2018 Development of direct oral anticoagulants and their antidotes has led to the need to reconsider the eligibility of acute stroke patients who have been taking oral anticoagulants for intravenous thrombolysis.
Kazunori Toyoda +2 more
doaj +1 more source
European Journal of Clinical Investigation, Volume 55, Issue 9, September 2025.Effective stroke prevention in AF requires a comprehensive holistic approach incorporating appropriate risk stratification, guideline‐adherent anticoagulation and management of underlying cardiovascular conditions and other comorbidities. The ABC pathway, supported by characterisation using the 4S‐AF framework, provides a structured approach to ...
Amir Askarinejad +4 more
wiley +1 more source